| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/04/2011 | CN101439116B Use of Chinese medicinal composition in preparing medicament for treating diabetes mellitus induced erectile dysfunction |
| 05/04/2011 | CN101428001B Preparation of O/W type medium chain fatty acid microemulsion |
| 05/04/2011 | CN101367873B Modified glucagon sample peptide-1analogue and modifying matter, and uses thereof |
| 05/04/2011 | CN101323850B Lactobacillus helveticus microcapsule, preparation and use thereof |
| 05/04/2011 | CN101243883B Health food with function of reducing blood sugar and its preparation |
| 05/04/2011 | CN101200427B Compounds and method for preparing same |
| 05/04/2011 | CN101184543B Method of preparing lycopene-enriched formulations that are free of organic solvents, formulations thus obtained, compositions comprising said formulations and use of same |
| 05/04/2011 | CN101112191B Method for breeding health-care chook |
| 05/04/2011 | CN101040657B Expanded pelleted feed for black eel fishes without pollution |
| 05/04/2011 | CN101019627B Micro jet and instantaneous high pressure process of preparing whole lily powder |
| 05/03/2011 | US7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/03/2011 | US7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 05/03/2011 | US7935699 Pyrazole glucokinase activators |
| 05/03/2011 | US7935690 Pharmaceutical composition |
| 05/03/2011 | US7935688 Vitamin D-like compound |
| 05/03/2011 | CA2629865C 2,3,4,5-tetrahydroxy-6-sulfooxy hexanoic acid pharmaceutically acceptable salts and equilibrium forms thereof, processes for their preparation, prarmaceutical compositions comprising such compounds and their medical use |
| 05/03/2011 | CA2489824C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 05/03/2011 | CA2476343C 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors |
| 05/03/2011 | CA2473026C 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 05/03/2011 | CA2467517C Substituted benzoxazoles and analogues as estrogenic agents |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2443632C Timed pulse release composition |
| 05/03/2011 | CA2438480C Glucocorticoid receptor modulators |
| 05/03/2011 | CA2438085C Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 05/03/2011 | CA2421109C Efficient method for producing compositions enriched in anthocyanins |
| 05/03/2011 | CA2342966C Gene alteration in the gene for the gbeta3 subunit of the human g protein |
| 05/03/2011 | CA2283680C Calcium phosphopeptide complexes |
| 05/03/2011 | CA2174961C Desferrioxamine oral delivery system |
| 04/28/2011 | WO2011050263A2 Systemic immunosuppression in the treatment of age related macular degeneration and diabetic retinopathy |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011050163A1 Method of preventing type 1 diabetes |
| 04/28/2011 | WO2011050052A2 Protein agent for diabetes treatment and beta cell imaging |
| 04/28/2011 | WO2011049520A1 Adamantyl iminocarbonyl-substituted pyrimidines as inhibitors of 1 1 betahsd1 |
| 04/28/2011 | WO2011049475A1 The new application of 2-pyrrolidone derivatives |
| 04/28/2011 | WO2011049400A2 Pharmaceutical composition containing acid addition salt of n,n-dimethyl imidocarbonimidic diamide for anti-cancer |
| 04/28/2011 | WO2011049344A2 Method of preparing sitagliptin and intermediates used therein |
| 04/28/2011 | WO2011049122A1 Pravastatin sodium tablet rapidly disintegrating in oral cavity and method for producing same |
| 04/28/2011 | WO2011049053A1 Intestinal mucosa-inherent myeloid cells inhibiting t cell activation and utilization of same |
| 04/28/2011 | WO2011048936A1 Aminothiazole derivative |
| 04/28/2011 | WO2011048479A2 Compositions that include anthocyanidins and methods of use |
| 04/28/2011 | WO2011048148A2 Glycoside derivative and uses thereof |
| 04/28/2011 | WO2011048136A1 Use of extracts from salonum glaucophyllum for treating bone metabolism disorders and kidney disorders |
| 04/28/2011 | WO2011048125A1 Oral delivery of therapeutically effective lna oligonucleotides |
| 04/28/2011 | WO2011048112A1 Glycoside derivatives and uses thereof |
| 04/28/2011 | WO2011048070A1 Methods and pharmaceutical compositions for the treatment of disorders of glucose homeostasis |
| 04/28/2011 | WO2011047530A1 Carotenoid derivatives, preparation method and use thereof |
| 04/28/2011 | WO2011047518A1 Enteral nutrition comprising marine bioactive polysaccharide, preparation method and use thereof |
| 04/28/2011 | WO2011047481A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/28/2011 | WO2011009084A3 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 04/28/2011 | WO2011006070A3 Genetic association of polymorphisms in perilipin (plin) gene with resistance to weight loss |
| 04/28/2011 | WO2010086454A9 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/28/2011 | US20110098356 Production and Purification of Esters of Polyunsaturated Fatty Acids |
| 04/28/2011 | US20110098330 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 04/28/2011 | US20110098328 Heterocyclic derivatives as modulators of ion channels |
| 04/28/2011 | US20110098320 Lactam Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 |
| 04/28/2011 | US20110098319 Fatty acid derivatives for oral administration endowed with high palatability |
| 04/28/2011 | US20110098315 Pharmaceutical compositions of rosuvastatin calcium |
| 04/28/2011 | US20110098311 Compositions for treatment of cystic fibrosis and other chronic diseases |
| 04/28/2011 | US20110098304 Small molecule inhibitors of PARP activity |
| 04/28/2011 | US20110098297 Fused ring compounds and use thereof |
| 04/28/2011 | US20110098295 Methods of treating anxiety, itching and psychiatric disorders |
| 04/28/2011 | US20110098289 Method for treating obesity |
| 04/28/2011 | US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/28/2011 | US20110098269 Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands |
| 04/28/2011 | US20110098265 Methods for reducing cravings and impulses associated with addictive and compulsive behaviors |
| 04/28/2011 | US20110098262 Corroles for neuroprotection and neurorescue |
| 04/28/2011 | US20110098259 Pregnane steroids and their use in the treatment of cns disorders |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/28/2011 | US20110098245 Agent for preventing or ameliorating obesity |
| 04/28/2011 | US20110098244 Process for Isolating Sialic Acid Containing Oligosaccharides, and the Compositions Containing Sialic Acid Containing Oligosaccharides Obtainable Thereby |
| 04/28/2011 | US20110098240 Pharmaceutical composition comprising a sglt2 inhibitor in combination with a dpp-iv inhibitor |
| 04/28/2011 | US20110098237 Methods for inhibiting drug degradation |
| 04/28/2011 | US20110098236 Diamide inhibitors of cytochrome p450 |
| 04/28/2011 | US20110098220 Methods and kits for preventing hypoglycemia |
| 04/28/2011 | US20110098218 Modulators of stat3 signalling |
| 04/28/2011 | US20110098217 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| 04/28/2011 | US20110098216 Therapeutic uses of colostrinin |
| 04/28/2011 | US20110098213 Novel peptides for use in the treatment of obesity |
| 04/28/2011 | US20110098212 Cytokine |
| 04/28/2011 | US20110097413 Solid state forms of deferasirox salts and process for the preparation thereof |
| 04/28/2011 | US20110097394 Type a gelatin capsule containing pufa in free acid form |
| 04/28/2011 | US20110097390 Ultra-Small RNAs as Toll-Like Receptor-3 Antagonists |
| 04/28/2011 | US20110097386 Stabilized glucagon solutions |
| 04/28/2011 | US20110097363 Therapeutically Effective Preparations of Insulin |
| 04/28/2011 | US20110097340 Fully human anti-vegf antibodies and methods of using |
| 04/28/2011 | US20110097331 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 04/28/2011 | US20110097326 Anti-trkb antibodies |
| 04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
| 04/28/2011 | US20110097303 Methods and compositions for treating and preventing viral infections |
| 04/28/2011 | DE102006031813B4 Verwendung basischer Acetophenone als Hemmstoffe von NO-Synthasen Using basic acetophenones as inhibitors of NO synthases |
| 04/28/2011 | CA2780165A1 Use of extracts from salonum glaucophyllum for treating bone metabolism disorders and kidney disorders |
| 04/28/2011 | CA2778384A1 Glycoside derivative and uses thereof |
| 04/28/2011 | CA2778349A1 Novel compositions for preventing and/or treating lysosomal storage disorders |
| 04/28/2011 | CA2778331A1 Methods of using anti-cd3 antibodies to prevent weight gain |
| 04/28/2011 | CA2777938A1 Method of preventing type 1 diabetes |
| 04/28/2011 | CA2777231A1 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone |
| 04/28/2011 | CA2776407A1 Method of preparing sitagliptin and intermediates used therein |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |